A synthetic biology approach for a vaccine platform against known and newly emerging serotypes of bluetongue virus. (2014)
Attributed to:
Improving existing vaccine platforms to minimise the economic impact of emerging Bluetongue virus (BTV) serotypes
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1128/jvi.02183-14
PubMed Identifier: 25142610
Publication URI: http://europepmc.org/abstract/MED/25142610
Type: Journal Article/Review
Volume: 88
Parent Publication: Journal of virology
Issue: 21
ISSN: 0022-538X